Case Report
BibTex RIS Cite

Akkiz hemofilide intramuskuler enjeksiyona bağlı hematom

Year 2019, , 306 - 308, 20.09.2019
https://doi.org/10.19161/etd.610880

Abstract

Akkiz hemofili, faktör 8’e karşı otoantikor
gelişmesi sonucu oluşan oldukça nadir görülen bir koagulasyon bozukluğudur.
Toplumda görülme sıklığı 1-4/1.000.000 olup sıklıkla ileri yaşlarda ortaya çıkmaktadır.
Hastalık 16 yaş altındaki çocuklarda 0.0045/milyon; 85 yaş üzerinde
14.7/milyon/yıl sıklığında görülür. Genellikle otoimmun, romatizmal veya malign
hastalıklar, gebelik ve ilaçlar ile ilişkili oluşur. Hastaların yaklaşık yarısında
etiyolojik faktör tespit edilemez. Başlıca belirtisi kas içine oluşan spontan kanamaların
varlığıdır. Burada akkiz hemofili hastasında gelişen bir hematom olgusu sunulmaktadır. 

References

  • Collins PW. Therapeutic challenges in acquired factor VIII deficiency. ASH Education Book 2012; 1: 369-74.
  • Franchini M, Manucci PM. Acquired haemophilia: A 2013 update. Thromb Haemost 2013; 110 (6): 1114-20.
  • Kessler1 CM, Knobl P. Acquired haemophilia: an overview for clinical practice. Eur J Haematol 2015; 95 (Suppl 81): 36-44.
  • Huang YW, Saidi P, Philipp C. Acquired factor VIII inhibitors in non-haemophilic patients: clinical experience of 15 cases. Haemophilia 2004; 10 (6): 713-21.
  • Huth-Kühne A, Baudo F, Collins P, et al. International recommendations on the diagnosis and treatment of patients with acquired hemophilia A. Haematologica 2009; 94 (4): 566-75.
  • Ma AL and Carrizosa D. Acquired Factor VIII Inhibitors: Pathophysiology and Treatment. Hematology Am Soc Hematol Educ Program 2006; 431-7.
  • Cohen AJ, Kessler CM. Acquired inhibitors. Baillieres Clin Haematol 1996; 9 (2): 331-54.
Year 2019, , 306 - 308, 20.09.2019
https://doi.org/10.19161/etd.610880

Abstract

Acquired hemophilia is a rare coagulopathy that results in
autoantibody development against factor 8. The incidence in the society is 1-4
/ 1.000.000 and it frequently occurs at older ages. The disease occurs in children
under 16 years of age with a frequency of 0.0045 / million, and a frequency of 14.7/million/year
over 85 years. It is usually associated with autoimmune, rheumatic or malign diseases,
pregnancy and medications. Approximately half of the patients cannot be identified
with the etiologic factor. The main symptom is the presence of spontaneous hemorrhages
in the muscle. Here we present a hematoma in a patient with acquired hemophilia.

References

  • Collins PW. Therapeutic challenges in acquired factor VIII deficiency. ASH Education Book 2012; 1: 369-74.
  • Franchini M, Manucci PM. Acquired haemophilia: A 2013 update. Thromb Haemost 2013; 110 (6): 1114-20.
  • Kessler1 CM, Knobl P. Acquired haemophilia: an overview for clinical practice. Eur J Haematol 2015; 95 (Suppl 81): 36-44.
  • Huang YW, Saidi P, Philipp C. Acquired factor VIII inhibitors in non-haemophilic patients: clinical experience of 15 cases. Haemophilia 2004; 10 (6): 713-21.
  • Huth-Kühne A, Baudo F, Collins P, et al. International recommendations on the diagnosis and treatment of patients with acquired hemophilia A. Haematologica 2009; 94 (4): 566-75.
  • Ma AL and Carrizosa D. Acquired Factor VIII Inhibitors: Pathophysiology and Treatment. Hematology Am Soc Hematol Educ Program 2006; 431-7.
  • Cohen AJ, Kessler CM. Acquired inhibitors. Baillieres Clin Haematol 1996; 9 (2): 331-54.
There are 7 citations in total.

Details

Primary Language Turkish
Subjects Health Care Administration
Journal Section Case Reports
Authors

Efser Erbil 0000-0001-6510-1257

Ali Zahit Bolaman 0000-0003-0651-5462

İrfan Yavaşoğlu 0000-0003-1703-2175

Publication Date September 20, 2019
Submission Date June 11, 2018
Published in Issue Year 2019

Cite

Vancouver Erbil E, Bolaman AZ, Yavaşoğlu İ. Akkiz hemofilide intramuskuler enjeksiyona bağlı hematom. ETD. 2019;58(3):306-8.

1724617243172472652917240      26515    

 26507    26508 26517265142651826513

2652026519